Colectomy rate in acute severe ulcerative colitis in the infliximab era.
about
Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitisRole of surgery in severe ulcerative colitis in the era of medical rescue therapyA retrospective analysis of 20-year data of the surgical management of ulcerative colitis patients in Taiwan: a study of Taiwan Society of Inflammatory Bowel Disease.Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?Current and emerging biologics for ulcerative colitis.Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update.Pros and cons of medical management of ulcerative colitis.Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort studyReview article: the practical management of acute severe ulcerative colitis.Safety and efficacy of Profermin® to induce remission in ulcerative colitis.The pattern and outcome of acute severe colitis.Trends in the surgical treatment of ulcerative colitis over time: increased mortality and centralization of care.Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease.Health-related quality of life in pediatric ulcerative colitis patients on conventional medical treatment compared to those after restorative proctocolectomy.Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis.The positioning of colectomy in the treatment of ulcerative colitis in the era of biologic therapy.European evidence based consensus for endoscopy in inflammatory bowel disease.Surgical management of ulcerative colitis in the era of biologicals.A think tank of the Italian Society of Colorectal Surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: ulcerative colitis.Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy.Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis.As Infliximab Use for Ulcerative Colitis Has Increased, so Has the Rate of Surgical Resection.A reappraisal of the ileo-rectal anastomosis in ulcerative colitis.Surgical treatment of ulcerative colitis in the biologic therapy era.Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.Does intramesorectal proctectomy with rectal eversion affect postoperative complications compared to standard total mesorectal excision in patients with ulcerative colitis?Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.Managing chronic disease in Ireland: hospital admission rates and clinical outcomes in a large ulcerative colitis population.Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.Early Surgical Intervention for Acute Ulcerative Colitis Is Associated with Improved Postoperative Outcomes.Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.Reducing colorectal anastomotic leakage with tissue adhesive in experimental inflammatory bowel disease.
P2860
Q26823221-4FD2E712-4B8F-41B7-87E0-B1EEFB0AA00DQ26830235-C29AAEB2-C6D4-4A9A-AFF3-49771CB8DB58Q31115745-60FF770B-57CF-4DAA-9CC5-1B8B178228C1Q33564081-D752F7DA-F823-4402-8DD7-4D2BEB988960Q34809305-253CBC37-517A-4492-9B47-BB456DA0CEB1Q35026302-9D85281A-FE05-4795-B88F-DC0C544282F9Q35100726-F911BD66-5F2B-4412-8B4B-EFCFAE6E2518Q35882026-9E455F3F-BBF3-43A1-B06E-03589AA2E33DQ35883580-F1F685C1-FA1E-44C0-9CC5-13C29C65ADC1Q35904302-F0019FCA-B68F-4979-B599-EA41C7174D9CQ37814560-D3E5A5FF-3F1E-4BEB-9297-5D3F1B80EF71Q37821792-7603BB89-3CA3-46ED-A735-846BCB4EFAE8Q37965581-4875A28D-BBF4-4A97-AFEF-399C49B7531BQ37983558-68696DE0-D30A-4F38-89D7-43CF011F6185Q38036920-AA55BAEB-475E-4608-A0A0-2BD6682890E1Q38056526-46620CD1-3216-486E-870B-C408E412C25AQ38056807-04FEB897-E81E-4997-BEE3-E5E9B554D16CQ38121000-F3ED4145-5823-4680-A677-F31434BE0C58Q38159096-1B98BD05-D0FA-4790-8D4B-F25CE15BDB27Q38249428-E457FA0F-5F33-430E-90E9-91D34BF3DD90Q38589686-63C3A928-EBB3-4F5E-9A50-1694D5797B15Q38653299-1EDF21E8-B48D-4BF8-8082-C333B07DFE71Q38986219-925E50A8-CCC1-46DF-B1B2-D080560DE5BBQ39292875-92A313FB-559B-494F-9996-AD8F290488EEQ41088872-5E0826F1-D70B-48D9-A932-00CCDE859114Q42728456-F1E47943-790F-4385-B3FF-A870DF394E0BQ43496310-50CD6642-30C9-4BC7-83DF-060886BF601AQ44187131-D5C38EDB-D91D-4F36-BBF1-5BC5CDB3AF7DQ44593368-DBFF005C-CCFE-40A7-9B51-2EF9244BDB80Q46599046-E85852BD-4E00-4ACC-B0F7-4C428792DA6FQ46875109-B4CC2BBF-432D-4995-84A7-217963DD9DFAQ48603169-2FF2BADF-65C1-495E-A28B-1CEA65DF382EQ51544073-30F40BAD-0D8D-4267-A014-65ECA3470F31Q53062022-0C676A52-952A-41E8-BDDC-9FB5D7ABA8FFQ53287014-B8368D9D-4094-4DE4-A416-5057E1B377A7
P2860
Colectomy rate in acute severe ulcerative colitis in the infliximab era.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Colectomy rate in acute severe ulcerative colitis in the infliximab era.
@en
Colectomy rate in acute severe ulcerative colitis in the infliximab era.
@nl
type
label
Colectomy rate in acute severe ulcerative colitis in the infliximab era.
@en
Colectomy rate in acute severe ulcerative colitis in the infliximab era.
@nl
prefLabel
Colectomy rate in acute severe ulcerative colitis in the infliximab era.
@en
Colectomy rate in acute severe ulcerative colitis in the infliximab era.
@nl
P2093
P1476
Colectomy rate in acute severe ulcerative colitis in the infliximab era.
@en
P2093
R Caprilli
R Luchetti
V Clemente
P304
P356
10.1016/J.DLD.2008.03.014
P577
2008-05-09T00:00:00Z